Pfizer plans to seek FDA approval for 3rd vaccine dose to boost immunity
In August, Pfizer plans to ask the Food and Drug Administration for emergency authorization of a third dose, Pfizer’s Dr. Mikael Dolsten said.
In this March 2021 photo provided by Pfizer, vials of the Pfizer-BioNTech COVID-19 vaccine are prepared for packaging at the company’s facility in Puurs, Belgium.
Pfizer via AP
July 8, 2021 | 6:06 PM
Email
Pfizer is about to seek U.S. authorization for a third dose of its COVID-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant.